药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Enprofylline
Siltuximab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Siltuximab.
Enprofylline
Vedolizumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Vedolizumab.
Enprofylline
Secukinumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Secukinumab.
Enprofylline
Fluprednidene
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluprednidene.
Enprofylline
Obinutuzumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Obinutuzumab.
Enprofylline
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Dimethyl fumarate.
Enprofylline
Fluticasone furoate
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluticasone furoate.
Enprofylline
Certolizumab pegol
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Certolizumab pegol.
Enprofylline
Carfilzomib
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Carfilzomib.
Enprofylline
Teriflunomide
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Teriflunomide.
Enprofylline
Belimumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Belimumab.
Enprofylline
Eribulin
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Eribulin.
Enprofylline
Wortmannin
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Wortmannin.
Enprofylline
Pralatrexate
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Pralatrexate.
Enprofylline
Bendamustine
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Bendamustine.
Enprofylline
Belatacept
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Belatacept.
Enprofylline
Golimumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Golimumab.
Enprofylline
Abetimus
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Abetimus.
Enprofylline
Mepolizumab
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Mepolizumab.
Enprofylline
Rilonacept
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Rilonacept.